Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
INCUS Performance developed wearable technology and data analytics platforms for endurance athletes. The company achieved recognition as AI Company of the Year at the 2022 British Data Awards[1] and had expanded from swimming and triathlon to running analytics, plus a Mixed Reality offering using 5G connectivity. However, the company ceased trading in early 2023 following withdrawal of crucial cornerstone investment due to broader VC funding market challenges[3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INCUS Performance.